Literature DB >> 18577762

Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.

Amy J Zeigler1, Karen J McAllen, Martha G Slot, Jeffrey F Barletta.   

Abstract

BACKGROUND: While medication reconciliation (MR) has been shown to reduce medication errors by limiting errors of transcription, omission, and duplicate therapy, its impact on the provision of unnecessary prophylaxis is largely unknown.
OBJECTIVE: To determine the effect of MR on the incidence of prolonged stress ulcer prophylaxis (SUP) across the continuum of care from hospital admission to discharge as well as evaluate clinical conditions associated with prolonged SUP.
METHODS: This retrospective study assessed patients who were admitted to the intensive care unit (ICU) and had SUP initiated. Patients were excluded if they were receiving gastroprotective therapy prior to ICU admission, were being treated for an acute gastrointestinal hemorrhage, or died. The need for SUP was determined using risk factors adapted from evidence-based guidelines developed by the American Society of Health-System Pharmacists. The use of SUP was assessed upon transfer from the ICU to a non-ICU setting and at hospital discharge. Results were compared between pre-MR and post-MR groups.
RESULTS: Data from 114 (pre-MR, n = 53; post-MR, n = 61) medical and surgical ICU patients were evaluated. There was no significant difference in the use of prolonged SUP upon transfer from the ICU to a non-ICU setting in the pre-MR and post-MR groups, respectively (85% [45/53] vs 79% [48/61], p = 0.393). Similarly, there was no significant difference in the use of prolonged SUP upon hospital discharge in the pre-MR and post-MR groups, respectively (14% [6/44] vs 23% [10/43], p = 0.247). There were no clinical conditions for which prolonged SUP use was predominant.
CONCLUSIONS: The strategy of MR alone will not decrease the incidence of prolonged SUP in hospitalized patients. Other techniques should be evaluated to encourage appropriate use of acid-suppressive agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577762     DOI: 10.1345/aph.1L123

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.

Authors:  Soumana C Nasser; Jeanette G Nassif; Fouad Mahfouz
Journal:  Pharm World Sci       Date:  2010-11-04

2.  Capsule Commentary on Scales et al., Unintentional Continuation of Medications Intended for Acute Illness After Hospital Discharge: A Population-Based Cohort Study.

Authors:  Shoshana J Herzig
Journal:  J Gen Intern Med       Date:  2016-02       Impact factor: 5.128

Review 3.  Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.

Authors:  Jeffrey F Barletta; David A Sclar
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

Review 4.  Improving clinical handover between intensive care unit and general ward professionals at intensive care unit discharge.

Authors:  Nelleke van Sluisveld; Gijs Hesselink; Johannes Gerardus van der Hoeven; Gert Westert; Hub Wollersheim; Marieke Zegers
Journal:  Intensive Care Med       Date:  2015-02-12       Impact factor: 17.440

5.  Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.

Authors:  Sooyoung Shin
Journal:  Ther Clin Risk Manag       Date:  2015-05-24       Impact factor: 2.423

6.  Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.

Authors:  Devada Singh-Franco; David R Mastropietro; Miriam Metzner; Michael D Dressler; Amneh Fares; Melinda Johnson; Daisy De La Rosa; William R Wolowich
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

7.  Medication-related interventions to improve medication safety and patient outcomes on transition from adult intensive care settings: a systematic review and meta-analysis.

Authors:  Richard S Bourne; Jennifer K Jennings; Maria Panagioti; Alexander Hodkinson; Anthea Sutton; Darren M Ashcroft
Journal:  BMJ Qual Saf       Date:  2022-01-18       Impact factor: 7.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.